FDA recall D-1762-2019

Infusion Options, Inc. · Class II · drug

Product

Cytarabine 128 MG/250 ML D5W IVPB; Cytarabine 20 MG / 1 ML SQ SYRINGE Cytarabine 70 MG QS 6 ML PF NS SYRINGE; Cytarabine 100 MG QS 3 ML PF NS SYRINGE, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

Reason for recall

Lack of Assurance of Sterility

Distribution

NY only

Key facts

Status: Terminated
Initiation date: 2019-06-12
Report date: 2019-08-21
Termination date: 2025-03-21
Voluntary/Mandated: Voluntary: Firm initiated
Location: Brooklyn, NY, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1762-2019